Citation Impact
Citing Papers
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
2006 Standout
A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against Shigella flexneri 2a Infection
2009
The changing epidemiology of human monkeypox—A potential threat? A systematic review
2022 Standout
Review on Zinc Oxide Nanoparticles: Antibacterial Activity and Toxicity Mechanism
2015 Standout
Diagnosis of Imported Monkeypox, Israel, 2018
2019
Mauve: Multiple Alignment of Conserved Genomic Sequence With Rearrangements
2004 Standout
Immunization of seronegative infants with hepatitis A vaccine (HAVRIX®; SKB): a comparative study of two dosing schedules
1997
Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies
2014 Standout
Cellular and molecular mechanisms of fibrosis
2007 Standout
Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants
2004
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
2002 Standout
Reaching a consensus on management practices and vaccine development targets for mitigation of infectious diarrhoea among deployed US military forces
2008
Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited
2009
Toll-like receptor control of the adaptive immune responses
2004 Standout
New strategies for using mucosal vaccination to achieve more effective immunization
1994
Does immunoglobulin interfere with the immunogenicity to Pasteur Mérieux inactivated hepatitis A vaccine?
1997
The Modular Structure of the Inner-Membrane Ring Component PrgK Facilitates Assembly of the Type III Secretion System Basal Body
2014 StandoutNobel
Improved methods for producing outer membrane vesicles in Gram-negative bacteria
2004
BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons
2011 Standout
Uric Acid and Cardiovascular Risk
2008 Standout
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 Standout
Mucosal immunity and vaccines
2005 Standout
Engineering the perfect (bacterial) cancer therapy
2010 Standout
Hydrogel nanoparticles in drug delivery
2008 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
A Refined Model of the Prototypical Salmonella SPI-1 T3SS Basal Body Reveals the Molecular Basis for Its Assembly
2013 StandoutNobel
Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008
2011 Standout
Induction of neutralising antibodies restricts the use of human granulocyte/macrophage colony stimulating factor for vaccine studies in rhesus macaques
2004 StandoutNobel
Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice
2007
Fibrotic disease and the TH1/TH2 paradigm
2004 Standout
A Systematic Review of Quasi-Experimental Study Designs in the Fields of Infection Control and Antibiotic Resistance
2005
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
2001 Standout
Pathogenic Escherichia coli
2004 Standout
Progress in enteric vaccine development
2004
Uric acid, evolution and primitive cultures
2005
Hyperuricaemia in the Pacific: why the elevated serum urate levels?
2013
Vaccines to Prevent Viral Hepatitis
1997
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Suppression of Superoxide-Generating Ability during Differentiation of Monocytes to Dendritic Cells
1996
A Program to Control an Outbreak of Hepatitis A in Alaska by Using an Inactivated Hepatitis A Vaccine
1996
The Common Structural Architecture of Shigella flexneri and Salmonella typhimurium Type Three Secretion Needles
2013 StandoutNobel
Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains
2003
Prevention ofHaemophilus influenzaeType b Colonization by Vaccination: Correlation with Serum Anti‐Capsular IgG Concentration
2000
Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice
1998
A spindle-like apparatus guides bacterial chromosome segregation
2010 StandoutNobel
Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants
2002
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults
1999
Comparison of immunogenicity of two hepatitis A vaccines — VAQTA® and HAVRIX® — in young adults
1999
Hepatitis A vaccine: Indirect evidence of immune memory 12 years after the primary course
2003
Abrogation of Oral Tolerance by Feeding Encapsulated Antigen
2000
Global epidemiology of gout: prevalence, incidence and risk factors
2015 Standout
Glycoproteomics
2022 StandoutNobel
Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells.
1998
Intestinal Immune Responses to an Inactivated Oral Enterotoxigenic Escherichia coli Vaccine and Associated Immunoglobulin A Responses in Blood
1998
Induction of anti-recombinant human granulocyte-macrophage colony- stimulating factor (Escherichia coli-derived) antibodies and clinical effects in nonimmunocompromised patients
1994
Epidemiology and Prevention of Hepatitis A in Travelers
1994
Hyperuricaemia and gout in Western Samoans
1981
Polar targeting of Shigella virulence factor IcsA in Enterobacteriacae and Vibrio
2001
NoncapsulatedKlebsiella pneumoniaeBearing Mannose-Containing O Antigens Is Rapidly Eradicated from Mouse Lung and Triggers Cytokine Production by Macrophages following Opsonization with Surfactant Protein D
2005
Complete Genome Sequence and Comparative Genomics ofShigella flexneriSerotype 2a Strain 2457T
2003
Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and Prevention
2005 Standout
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Type III Secretion Systems and Disease
2007
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
1999 Standout
Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
1999 Standout
Characterization of Functional Oligosaccharide Mimics of the Shigella flexneri Serotype 2a O-Antigen: Implications for the Development of a Chemically Defined Glycoconjugate Vaccine
2006
Blockwise Approach to Fragments of the O-Specific Polysaccharide of Shigella flexneri Serotype 2a: Convergent Synthesis of a Decasaccharide Representative of a Dimer of the Branched Repeating Unit1
2004
Attenuated Shigella flexneri 2a Δ guaBA Strain CVD 1204 Expressing Enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 Fimbriae as a Live Mucosal Vaccine against Shigella and ETEC Infection
2001
Gout in black South Africans: a clinical and genetic study.
1994
Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling
2001
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Gout
2021 Standout
Serum Immunoglobulin G Antibody Responses to Bordetella pertussis Lipooligosaccharide and B. parapertussis Lipopolysaccharide in Children with Pertussis and Parapertussis
2001
Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane Vesicles
2010 Standout
Oral vaccination with alginate microsphere systems
1996
Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspecies
2005 Standout
The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin
1995 StandoutNobel
Protein glycosylation: Sweet or bitter for bacterial pathogens?
2019
Serum uric acid concentrations in a Xhosa community in the Transkei of Southern Africa.
1976
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
1999 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Correlates of Protection Induced by Vaccination
2010 Standout
Works of Guy Robin being referenced
Clinical and Immune Responses after Revaccination of Israeli Adults with the Lister Strain of Vaccinia Virus
2004
Measles antibody prevalence rates among young adults in Israel
2002
Characterization and Quantitative Analysis of Serum IgG Class and Subclass Response toShigella sonneiandShigella flexneri2a Lipopolysaccharide following NaturalShigellaInfection
1997
Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults
1997
Role of Cytokines in the Maturation and Function of Macrophages
2002
Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines
1999
Serum uric acid concentrations in an urbanized South African Negro population.
1974
Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models
1993
Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination
1996
Vaccination against Shigellosis with Attenuated Shigella flexneri 2a Strain SC602
1999
Safety and Immunogenicity of Two Different Lots of the Oral, Killed Enterotoxigenic Escherichia coli -Cholera Toxin B Subunit Vaccine in Israeli Young Adults
2000
Oral or intranasal immunization with shigella LPS complexed to proteosomes induces intestinal and serum IgA and IgG
1992
Depression of the Immune Response to an Inactivated Hepatitis A Vaccine Administered Concomitantly with Immune Globulin
1993
Human recombinant granulocyte-macrophage colony-stimulating factor augments viability and cytotoxic activities of human monocyte-derived macrophages in long-term cultures.
1991
Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers
1996